Țară: Malaezia
Limbă: engleză
Sursă: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
ENROFLOXACIN
My Vet Care Sdn Bhd
ENROFLOXACIN
100 Tablets; 50 Tablets
LelyPharma B. V.
ENROTRON FLAVOUR 50 MG Enrofloxacin Tablets B. PACKAGE LEAFLET ENROTRON FLAVOUR 50 MG Enrofloxacin Tablets PACKAGE LEAFLET FOR: ENROTRON FLAVOUR 50 MG, tablets for dogs 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURER Name and address of the manufacturer LelyPharma B. V. Zuiveringweg 42 8243 PZ Lelystad The Netherlands Marketing authorisation holder: My Vet Care Sdn. Bhd. A-G-3A, Red Ruby Shop Apartment Jalan Indah 2/4, Taman Universiti Indah 43300 Seri Kembangan Selangor, Malaysia 2. NAME OF THE VETERINARY MEDICINAL PRODUCT ENROTRON FLAVOUR 50 MG, tablets Enrofloxacin 3. STATEMENT OF THE ACTIVE SUBSTANCE AND OTHER INGREDIENTS 1 tablet contains: ACTIVE SUBSTANCE: Enrofloxacin ...................... 50.0 mg White to off-white, round tablet with one break line and one decorative line. The tablet can be divided into two equal parts. ENROTRON FLAVOUR 50 MG Enrofloxacin Tablets 4. INDICATIONS For the treatment of bacterial single or combined infections of the respiratory, alimentary or urinary tract, the skin or wounds, caused by enrofloxacin-sensitive Gram-negative and Gram-positive bacteria: _E. _ _coli_, _Pasteurella_ spp., _Haemophilus_ spp. and staphylococci. 5. CONTRAINDICATIONS Do not use in young or growing dogs (dogs aged less than 12 months (small breed) or less than 18 months (large breed)) as the product may cause epiphyseal cartilage alterations in growing puppies. Do not use in dogs having seizure disorders, since enrofloxacin may cause CNS stimulation. Do not use in dogs with known hypersensitivity to fluoroquinolones or to any of the excipients of the product. Do not use in case of resistance to quinolones, as there exists almost complete cross resistance to other quinolones and complete cross resistance to other fluoroquinolones. Do not use with tetracyclines, phenicols or macrolides because of potential antagonistic effects. See also section “Special warnings”. 6. ADVERSE REACTIONS In rare cases, vomiting and diarrhoea are observed. See section “Contraindication Citiți documentul complet